title: Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy.
abstract: Nutritional status influences muscle growth and athletic performance, but little is known about the effect of nutritional supplements, such as creatine, on satellite cell mitotic activity. The purpose of this study was to examine the effect of oral creatine supplementation on muscle growth, compensatory hypertrophy, and satellite cell mitotic activity. Compensatory hypertrophy was induced in the rat plantaris muscle by removing the soleus and gastrocnemius muscles. Immediately following surgery, a group of six rats was provided with elevated levels of creatine monohydrate in their diet. Another group of six rats was maintained as a non-supplemented control group. Twelve days following surgery, all rats were implanted with mini-osmotic pumps containing the thymidine analog 5-bromo-2'-deoxyuridine (BrdU) to label mitotically active satellite cells. Four weeks after the initial surgery the rats were killed, plantaris muscles were removed and weighed. Subsequently, BrdU-labeled and non-BrdU-labeled nuclei were identified on enzymatically isolated myofiber segments. Muscle mass and myofiber diameters were larger (P < 0.05) in the muscles that underwent compensatory hypertrophy compared to the control muscles, but there were no differences between muscles from creatine-supplemented and non-creatine-supplemented rats. Similarly, compensatory hypertrophy resulted in an increased (P < 0.05) number of BrdU-labeled myofiber nuclei, but creatine supplementation in combination with compensatory hypertrophy resulted in a higher (P < 0.05) number of BrdU-labeled myofiber nuclei compared to compensatory hypertrophy without creatine supplementation. Thus, creatine supplementation in combination with an increased functional load results in increased satellite cell mitotic activity.
authors.affiliation: Department of Anatomy, University of Wisconsin-Medical School, Madison, USA.
authors.forename: B
authors.initials: B
authors.lastname: Dangott
authors.forename: E
authors.initials: E
authors.lastname: Schultz
authors.forename: P E
authors.initials: PE
authors.lastname: Mozdziak
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001823:Body Composition; D001973:Bromodeoxyuridine; D003401:Creatine / Q000494:pharmacology*; D019587:Dietary Supplements; D006984:Hypertrophy; D008297:Male; D008938:Mitosis / Q000187:drug effects*; D018482:Muscle, Skeletal / Q000166:cytology / Q000187:drug effects; D051381:Rats; D015430:Weight Gain; D016474:Weight-Bearing
chemical_list: D001973:Bromodeoxyuridine; D003401:Creatine